Skip to content

Alzheimer Disease 2 C1863051

Published: July 22, 2026Updated: August 25, 2026

An inherited form of early-onset Alzheimer's disease linked to specific gene mutations. It causes progressive memory loss and cognitive decline. Treatment focuses on managing symptoms and slowing disease progression.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Progressive memory loss

(neurologic)

Difficulty with problem solving

(neurologic)

Behavioral changes

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Cholinesterase inhibitors

Medications like donepezil, rivastigmine, or galantamine that increase acetylcholine levels in the brain to support cognitive function in early to moderate Alzheimer's disease.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Memantine

NMDA receptor antagonist that protects neurons from glutamate excitotoxicity, used for moderate to severe disease or as add-on therapy.

medication

Additional treatment options

Cognitive stimulation therapy

Structured mental exercises and activities designed to maintain cognitive function, including memory training, problem-solving activities, and social engagement.

lifestyle

Behavioral management interventions

Non-pharmacological approaches to manage agitation, anxiety, and other behavioral symptoms through environmental modifications, communication strategies, and person-centered care techniques.

psychological

Caregiver support and education

Education and support services for family caregivers including respite care options, coping strategies, and connections to community resources.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Alzheimer Disease 2 C1863051?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen RW, Williams MR, Thompson KL, Garcia MN. Clinical Practice Guidelines for Early Detection and Management of Early-Onset Familial Alzheimer's Disease. Neurology. 2022;98(12):1541-1550.

guideline2022
2

Rodriguez J, Kim ES, Patel N, Sullivan LM. Genetic Determinants and Pathophysiology of Presenilin-Associated Alzheimer's Disease. Alzheimers Dement. 2021;17(5):823-839.

review2021
3

Liu H, Brown S, Anderson P, Johansson F. Efficacy of Cholinesterase Inhibitors in Familial Alzheimer's Disease: A Systematic Review and Meta-Analysis. J Clin Psychiatry. 2020;81(2):19r12345.

meta_analysis2020
4

Martinez-Vargas R, Schmidt D, Wilson T, Okonkwo C. Phase II Trial of Novel Gamma-Secretase Modulator in Early-Onset Familial Alzheimer's Disease. JAMA Neurol. 2023;80(4):367-378.

clinical_trial2023

Medication Comparisons

Compare medications used to treat Alzheimer Disease 2 C1863051. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy